292 related articles for article (PubMed ID: 33452304)
1. Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria.
Yang KM; Kim JS; Kim HS; Kim YY; Oh JK; Jung HW; Park DS; Bae KH
Sci Rep; 2021 Jan; 11(1):1631. PubMed ID: 33452304
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of Lactobacillus reuteri on periodontopathic and cariogenic bacteria.
Kang MS; Oh JS; Lee HC; Lim HS; Lee SW; Yang KH; Choi NK; Kim SM
J Microbiol; 2011 Apr; 49(2):193-9. PubMed ID: 21538238
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria.
Sun M; Zhou Z; Dong J; Zhang J; Xia Y; Shu R
Microb Pathog; 2016 Oct; 99():196-203. PubMed ID: 27565090
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of red wine and oenological extracts against periodontal pathogens in a validated oral biofilm model.
Sánchez MC; Ribeiro-Vidal H; Esteban-Fernández A; Bartolomé B; Figuero E; Moreno-Arribas MV; Sanz M; Herrera D
BMC Complement Altern Med; 2019 Jun; 19(1):145. PubMed ID: 31226983
[TBL] [Abstract][Full Text] [Related]
5. Composition and Antibacterial Activity of the Essential Oils of Orthosiphon stamineus Benth and Ficus deltoidea Jack against Pathogenic Oral Bacteria.
Azizan N; Mohd Said S; Zainal Abidin Z; Jantan I
Molecules; 2017 Dec; 22(12):. PubMed ID: 29206142
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-encapsulated chlorhexidine against oral bacterial biofilms.
Seneviratne CJ; Leung KC; Wong CH; Lee SF; Li X; Leung PC; Lau CB; Wat E; Jin L
PLoS One; 2014; 9(8):e103234. PubMed ID: 25170958
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of viable and heat-killed probiotic strains against oral pathogens.
Chen YT; Hsieh PS; Ho HH; Hsieh SH; Kuo YW; Yang SF; Lin CW
Lett Appl Microbiol; 2020 Apr; 70(4):310-317. PubMed ID: 31955445
[TBL] [Abstract][Full Text] [Related]
8. Selected dietary (poly)phenols inhibit periodontal pathogen growth and biofilm formation.
Shahzad M; Millhouse E; Culshaw S; Edwards CA; Ramage G; Combet E
Food Funct; 2015 Mar; 6(3):719-29. PubMed ID: 25585200
[TBL] [Abstract][Full Text] [Related]
9. Probiotic Lactobacillus sp. inhibit growth, biofilm formation and gene expression of caries-inducing Streptococcus mutans.
Wasfi R; Abd El-Rahman OA; Zafer MM; Ashour HM
J Cell Mol Med; 2018 Mar; 22(3):1972-1983. PubMed ID: 29316223
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of hinokitiol against both antibiotic-resistant and -susceptible pathogenic bacteria that predominate in the oral cavity and upper airways.
Domon H; Hiyoshi T; Maekawa T; Yonezawa D; Tamura H; Kawabata S; Yanagihara K; Kimura O; Kunitomo E; Terao Y
Microbiol Immunol; 2019 Jun; 63(6):213-222. PubMed ID: 31106894
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of povidone-iodine against an artificial biofilm of Porphyromonas gingivalis and Fusobacterium nucleatum.
Hosaka Y; Saito A; Maeda R; Fukaya C; Morikawa S; Makino A; Ishihara K; Nakagawa T
Arch Oral Biol; 2012 Apr; 57(4):364-8. PubMed ID: 21958970
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial effects of blackberry extract target periodontopathogens.
González OA; Escamilla C; Danaher RJ; Dai J; Ebersole JL; Mumper RJ; Miller CS
J Periodontal Res; 2013 Feb; 48(1):80-6. PubMed ID: 22812456
[TBL] [Abstract][Full Text] [Related]
13. Rice peptide with amino acid substitution inhibits biofilm formation by Porphyromonas gingivalis and Fusobacterium nucleatum.
Matsugishi A; Aoki-Nonaka Y; Yokoji-Takeuchi M; Yamada-Hara M; Mikami Y; Hayatsu M; Terao Y; Domon H; Taniguchi M; Takahashi N; Yamazaki K; Tabeta K
Arch Oral Biol; 2021 Jan; 121():104956. PubMed ID: 33157493
[TBL] [Abstract][Full Text] [Related]
14. Copaifera reticulata oleoresin: Chemical characterization and antibacterial properties against oral pathogens.
Bardají DK; da Silva JJ; Bianchi TC; de Souza Eugênio D; de Oliveira PF; Leandro LF; Rogez HL; Venezianni RC; Ambrosio SR; Tavares DC; Bastos JK; Martins CH
Anaerobe; 2016 Aug; 40():18-27. PubMed ID: 27118478
[TBL] [Abstract][Full Text] [Related]
15. Effects of Sodium Tripolyphosphate on Oral Commensal and Pathogenic Bacteria.
Moon JH; Noh MH; Jang EY; Yang SB; Kang SW; Kwack KH; Ryu JI; Lee JY
Pol J Microbiol; 2019; 68(2):263-268. PubMed ID: 31257792
[TBL] [Abstract][Full Text] [Related]
16. Heat-killed Lactobacillus reuteri and cell-free culture supernatant have similar effects to viable probiotics during interaction with Porphyromonas gingivalis.
Geraldo BMC; Batalha MN; Milhan NVM; Rossoni RD; Scorzoni L; Anbinder AL
J Periodontal Res; 2020 Apr; 55(2):215-220. PubMed ID: 31691977
[TBL] [Abstract][Full Text] [Related]
17. Killing dental pathogens using antibacterial graphene oxide.
He J; Zhu X; Qi Z; Wang C; Mao X; Zhu C; He Z; Li M; Tang Z
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5605-11. PubMed ID: 25705785
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial effect of silver (I) carbohydrate complexes on oral pathogenic key species in vitro.
Reise M; Gottschaldt M; Matz C; Völpel A; Jandt KD; Schubert US; Sigusch BW
BMC Oral Health; 2016 Mar; 16():42. PubMed ID: 27009305
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of the de novo-derived antimicrobial peptide WLBU2 against oral bacteria.
Novak KF; Diamond WJ; Kirakodu S; Peyyala R; Anderson KW; Montelaro RC; Mietzner TA
Antimicrob Agents Chemother; 2007 May; 51(5):1837-9. PubMed ID: 17325219
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of the antiasthmatic drug zafirlukast against the oral pathogens Porphyromonas gingivalis and Streptococcus mutans.
Gerits E; Van der Massen I; Vandamme K; De Cremer K; De Brucker K; Thevissen K; Cammue BPA; Beullens S; Fauvart M; Verstraeten N; Michiels J
FEMS Microbiol Lett; 2017 Jan; 364(2):. PubMed ID: 28087617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
